High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab
Crossref DOI link: https://doi.org/10.1007/s12185-015-1880-3
Published Online: 2015-10-08
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okina, Sosei
Yanagisawa, Nobuyuki
Yokoyama, Maki
Sakurai, Yasutaka
Numata, Yoshiko
Umezawa, Atsuko
Higashihara, Masaaki
Murakumo, Yoshiki
Text and Data Mining valid from 2015-10-08